207 related articles for article (PubMed ID: 6374968)
21. Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes.
Okuno Y; Komada H; Sakaguchi K; Nakamura T; Hashimoto N; Hirota Y; Ogawa W; Seino S
Metabolism; 2013 Oct; 62(10):1470-6. PubMed ID: 23831440
[TBL] [Abstract][Full Text] [Related]
22. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
Sakai T; Ohneda A; Nihei J; Kobayashi T
Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
[TBL] [Abstract][Full Text] [Related]
23. Serum adiponectin is associated with fasting serum C-peptide in non-obese diabetic patients.
Furuta M; Tamai M; Hanabusa T; Yamamoto Y; Nanjo K; Sanke T
Diabetes Res Clin Pract; 2006 Jun; 72(3):302-7. PubMed ID: 16442181
[TBL] [Abstract][Full Text] [Related]
24. Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus.
Kosaka K; Kuzuya T; Hagura R; Yoshinaga H
Diabet Med; 1996 Sep; 13(9 Suppl 6):S109-19. PubMed ID: 8894494
[TBL] [Abstract][Full Text] [Related]
25. Human plasma C-peptide immunoreactivity: its correlation with immunoreactive insulin in diabetes, and chronic liver and renal diseases.
Kajinuma H; Kanazawa Y; Sando H; Hayashi M; Kawazu S; Kosaka K
Endocrinol Jpn; 1979 Feb; 26(1):65-73. PubMed ID: 436802
[TBL] [Abstract][Full Text] [Related]
26. Cyclosporin A does not delay insulin dependency in asymptomatic IDDM patients.
Rakotoambinina B; Timsit J; Deschamps I; Laborde K; Jos J; Boitard C; Assan R; Robert JJ
Diabetes Care; 1995 Nov; 18(11):1487-90. PubMed ID: 8722075
[TBL] [Abstract][Full Text] [Related]
27. Serum ketone response to glucagon as a marker of insulin dependency in diabetics.
Watanabe T; Sugiyama H; Uchimura I; Maezawa H
Diabetes Res Clin Pract; 1991 Nov; 14(2):107-12. PubMed ID: 1756681
[TBL] [Abstract][Full Text] [Related]
28. Preoperative insulin secretion ability and pancreatic parenchymal thickness as useful parameters for predicting postoperative insulin secretion in patients undergoing pancreaticoduodenectomy.
Yoshikawa A; Kozawa J; Okita K; Yoneda S; Okauchi Y; Uno S; Iwahashi H; Ohira T; Takiuchi D; Eguchi H; Takeda Y; Imagawa A; Shimomura I
Endocr J; 2012; 59(5):383-92. PubMed ID: 22374239
[TBL] [Abstract][Full Text] [Related]
29. Multicenter prevention trial of slowly progressive type 1 diabetes with small dose of insulin (the Tokyo study): preliminary report.
Maruyama T; Shimada A; Kanatsuka A; Kasuga A; Takei I; Yokoyama J; Kobayashi T
Ann N Y Acad Sci; 2003 Nov; 1005():362-9. PubMed ID: 14679093
[TBL] [Abstract][Full Text] [Related]
30. Islet cell antibody-positive versus -negative phenotypic type 2 diabetes in youth: does the oral glucose tolerance test distinguish between the two?
Tfayli H; Bacha F; Gungor N; Arslanian S
Diabetes Care; 2010 Mar; 33(3):632-8. PubMed ID: 20028940
[TBL] [Abstract][Full Text] [Related]
31. Treatment of poorly controlled non-insulin-dependent diabetic patients with Acarbose.
Scott RS; Knowles RL; Beaven DW
Aust N Z J Med; 1984 Oct; 14(5):649-54. PubMed ID: 6397178
[TBL] [Abstract][Full Text] [Related]
32. Human C-peptide immunoreactivity (CPR) in blood and urine - evaluation of a radioimmunoassay method and its clinical applications.
Kuzuya T; Saito T; Yoshida S; Matsuda A
Diabetologia; 1976 Oct; 12(5):511-8. PubMed ID: 976638
[TBL] [Abstract][Full Text] [Related]
33. Relation between the serum level of C-peptide and risk factors for coronary heart disease and diabetic microangiopathy in patients with type-2 diabetes mellitus.
Inukai T; Matsutomo R; Tayama K; Aso Y; Takemura Y
Exp Clin Endocrinol Diabetes; 1999; 107(1):40-5. PubMed ID: 10077354
[TBL] [Abstract][Full Text] [Related]
34. Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes.
Miyazaki Y; Matsuda M; DeFronzo RA
Diabetes Care; 2002 Mar; 25(3):517-23. PubMed ID: 11874940
[TBL] [Abstract][Full Text] [Related]
35. Pathophysiological study of the non-insulin-dependent phase of type I diabetes mellitus.
Torella R; Salvatore T; Cozzolino D; Grandillo F; Giugliano D
Acta Diabetol Lat; 1988; 25(2):161-72. PubMed ID: 3146849
[TBL] [Abstract][Full Text] [Related]
36. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications.
Scheen AJ; Castillo MJ; Lefèbvre PJ
Diabetes Metab; 1996 Dec; 22(6):397-406. PubMed ID: 8985647
[TBL] [Abstract][Full Text] [Related]
37. C-peptide immunoreactivity and insulin content in the diabetic human pancreas and the relation to the stability of diabetic serum glucose level.
Tasaka Y; Marumo K; Inoue Y; Hirata Y
Acta Endocrinol (Copenh); 1986 Nov; 113(3):355-62. PubMed ID: 3538738
[TBL] [Abstract][Full Text] [Related]
38. Plasma glucose response after intravenous injection of tolbutamide in insulin-treated type I and type II diabetic patients.
Mokuda O; Murakami I; Ikeda T; Tominaga M; Mashiba H
Exp Clin Endocrinol; 1988 Aug; 91(3):265-70. PubMed ID: 3075183
[TBL] [Abstract][Full Text] [Related]
39. The impact of insulin administration during the mixed meal tolerance test.
Besser RE; Jones AG; McDonald TJ; Shields BM; Knight BA; Hattersley AT
Diabet Med; 2012 Oct; 29(10):1279-84. PubMed ID: 22435709
[TBL] [Abstract][Full Text] [Related]
40. Disproportionately elevated proinsulin levels precede the onset of insulin-dependent diabetes mellitus in siblings with low first phase insulin responses. The Childhood Diabetes in Finland Study Group.
Røder ME; Knip M; Hartling SG; Karjalainen J; Akerblom HK; Binder C
J Clin Endocrinol Metab; 1994 Dec; 79(6):1570-5. PubMed ID: 7989457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
